A global biopharmaceutical company is looking for a Medical Affairs Director, Blood Cancer. The selected candidate will lead in-country medical activities for hematology assets and pipeline programs, while driving medical strategy, Field Medical execution, and cross-functional collaboration.
Responsibilities
Serve as the in-country medical lead for hematology assets and pipeline activities.
Represent Medical Affairs in cross-functional planning with regional and global partners.
Direct Field Medical execution, insight generation, and external scientific engagement, while coaching and developing Field Medical colleagues.
Support clinical development and research activities, including investigator engagement and site identification.
Lead medical strategy for congresses, symposia, advisory boards, and educational activities.
Deliver scientific presentations to healthcare professionals and key stakeholders.
Build trusted relationships and communicate local patient and physician insights to relevant stakeholders.
Requirements
MD or PhD with strong scientific expertise and extensive hematology experience.
More than 10–15 years of relevant pharmaceutical or biotechnology industry experience.
Strong knowledge of Medical Affairs, Clinical Development, and Japanese regulatory requirements.
Solid experience in drug development and lifecycle management.
Experience leading people and directing Field Medical activities.
Deep knowledge of solid tumors; immuno-hematology experience preferred.
Experience working in matrix organizations and collaborating cross-functionally.
Thorough understanding of the Japanese healthcare environment.
Ability to identify and shape strategic and tactical planning opportunities.
Excellent medical communication, analytical, and stakeholder management skills.
Publication record and translational or basic research experience are a plus.
Ability to manage multiple priorities while maintaining compliance standards.
Benefits
Hybrid working style.
Comprehensive welfare and insurance plan, with details to be shared during the offer process.
About the Company
A global biopharmaceutical company focused on discovering, developing, and commercializing treatments for patients with serious diseases. The company is science-driven and develops medicines based on its own research and technology capabilities, with multiple medicines approved in Japan.